13G Filing: Armistice Capital and Apricus Biosciences Inc. (APRI)

Page 5 of 10

Page 5 of 10 – SEC Filing


CUSIP No
03832V307
Item 1. (a). Name of Issuer:
Apricus Biosciences, Inc.
(b). Address of Issuer’s Principal Executive Offices:

11975 El Camino Real, Suite 300

San Diego, California 92130

United States of America

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Common Stock, par value $.001
(e). CUSIP Number:
03832V307

Follow Seelos Therapeutics Inc. (NASDAQ:SEEL)

Page 5 of 10